Utilidad de los biomarcadores en insuficiencia cardiaca en la práctica clínica

The assessment of patients with a suspected cardiac failure aims to an early and precise diagnosis and risk stratification. Only natriuretic peptides have demonstrated to be clinically useful. Brain natriuretic peptide stands out due to its diagnostic and prognostic value. However its results should be cautiously interpreted in the clinical context, bearing in mind possible confounders. The combination of markers can provide a better risk stratification and compensates the limitations of individual markers. Each new marker gives a new insight on the underlying physiopathology of cardiac failure and proposes new therapeutic approaches.

Saved in:
Bibliographic Details
Main Authors: Paredes C,Alejandro, Vega,Julián, de León,Ana, Kanacri,Andrés, Castro,Pablo, Baeza,Ricardo
Format: Digital revista
Language:Spanish / Castilian
Published: Sociedad Médica de Santiago 2013
Online Access:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872013001200010
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0034-98872013001200010
record_format ojs
spelling oai:scielo:S0034-988720130012000102014-10-10Utilidad de los biomarcadores en insuficiencia cardiaca en la práctica clínicaParedes C,AlejandroVega,Juliánde León,AnaKanacri,AndrésCastro,PabloBaeza,Ricardo Biological markers Heart failure Prognosis Troponin The assessment of patients with a suspected cardiac failure aims to an early and precise diagnosis and risk stratification. Only natriuretic peptides have demonstrated to be clinically useful. Brain natriuretic peptide stands out due to its diagnostic and prognostic value. However its results should be cautiously interpreted in the clinical context, bearing in mind possible confounders. The combination of markers can provide a better risk stratification and compensates the limitations of individual markers. Each new marker gives a new insight on the underlying physiopathology of cardiac failure and proposes new therapeutic approaches.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.141 n.12 20132013-12-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872013001200010es10.4067/S0034-98872013001200010
institution SCIELO
collection OJS
country Chile
countrycode CL
component Revista
access En linea
databasecode rev-scielo-cl
tag revista
region America del Sur
libraryname SciELO
language Spanish / Castilian
format Digital
author Paredes C,Alejandro
Vega,Julián
de León,Ana
Kanacri,Andrés
Castro,Pablo
Baeza,Ricardo
spellingShingle Paredes C,Alejandro
Vega,Julián
de León,Ana
Kanacri,Andrés
Castro,Pablo
Baeza,Ricardo
Utilidad de los biomarcadores en insuficiencia cardiaca en la práctica clínica
author_facet Paredes C,Alejandro
Vega,Julián
de León,Ana
Kanacri,Andrés
Castro,Pablo
Baeza,Ricardo
author_sort Paredes C,Alejandro
title Utilidad de los biomarcadores en insuficiencia cardiaca en la práctica clínica
title_short Utilidad de los biomarcadores en insuficiencia cardiaca en la práctica clínica
title_full Utilidad de los biomarcadores en insuficiencia cardiaca en la práctica clínica
title_fullStr Utilidad de los biomarcadores en insuficiencia cardiaca en la práctica clínica
title_full_unstemmed Utilidad de los biomarcadores en insuficiencia cardiaca en la práctica clínica
title_sort utilidad de los biomarcadores en insuficiencia cardiaca en la práctica clínica
description The assessment of patients with a suspected cardiac failure aims to an early and precise diagnosis and risk stratification. Only natriuretic peptides have demonstrated to be clinically useful. Brain natriuretic peptide stands out due to its diagnostic and prognostic value. However its results should be cautiously interpreted in the clinical context, bearing in mind possible confounders. The combination of markers can provide a better risk stratification and compensates the limitations of individual markers. Each new marker gives a new insight on the underlying physiopathology of cardiac failure and proposes new therapeutic approaches.
publisher Sociedad Médica de Santiago
publishDate 2013
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872013001200010
work_keys_str_mv AT paredescalejandro utilidaddelosbiomarcadoreseninsuficienciacardiacaenlapracticaclinica
AT vegajulian utilidaddelosbiomarcadoreseninsuficienciacardiacaenlapracticaclinica
AT deleonana utilidaddelosbiomarcadoreseninsuficienciacardiacaenlapracticaclinica
AT kanacriandres utilidaddelosbiomarcadoreseninsuficienciacardiacaenlapracticaclinica
AT castropablo utilidaddelosbiomarcadoreseninsuficienciacardiacaenlapracticaclinica
AT baezaricardo utilidaddelosbiomarcadoreseninsuficienciacardiacaenlapracticaclinica
_version_ 1755988441885048832